Patient Guide: A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 81 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06537414
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Hepatitis B Virus Infection, Hepatitis B
Phase: PHASE2

Find a Study Location Near You

This study is available at 81 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • San Francisco, California
  • San Jose, California
  • Minneapolis, Minnesota
  • • And 78 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily